PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?

• click to rate

  Posted by Two Blokes Jul 4 - Filed in Stock - 4 views
  
  Prothena slashes 63% of its workforce and axes birtamimab after trial failure, reshaping its pipeline and financial outlook. Shares plunge 53.5% YTD.